Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one

US10052322B2 · kind B2 · utility

Assignee

• Signal Pharmaceuticals, LLC · US

Inventors

• Anil Menon · Bound Brook, US
• Darshan Parikh · Bound Brook, US
• Dora Visky · Flemington, US
• Nathan Boersen · Summit, US
• Thomas Lee · Bedminster, US
• Xiaozhang Liang · Edison, US

Key dates

• Filing date: Oct 23, 2017
• Grant date: Aug 21, 2018
• Expiry date: Oct 23, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one.